Scoping Review vs. Systematic Review vs. Narrative Review: How to Choose the Right Method

Picking the wrong evidence synthesis method is one of the most common reasons a review protocol comes back with reviewer objections before the research itself has even started. The question of scoping review vs systematic review vs narrative review sounds like a technicality, but it decides your framework, your timeline, whether a protocol registry will accept you, and whether a journal will accept your methods section at all. This guide walks through what separates the three, how to decide which one your question actually needs, and what a completed scoping review looks like in practice, with real numbers from a published example rather than a hypothetical one.

What Is a Scoping Review?

A scoping review is a systematic method for mapping the extent, range, and nature of evidence on a topic. It identifies key concepts, sources of evidence, and gaps in the research, without pooling effect sizes and without formally rating the quality of individual studies. That last point is what separates it from a systematic review: a scoping review can include a much wider range of source types (trials, cohort studies, grey literature, guidelines) precisely because it is not trying to weigh them against each other for a single pooled answer.

The methodology traces back to Arksey and O’Malley, who published the first scoping review framework in 2005 (a five-stage process: identify the research question, identify relevant studies, select studies, chart the data, and collate/summarize/report results). Levac, Colquhoun, and O’Brien refined that framework in 2010, adding clearer guidance on defining the research question and on the role of stakeholder consultation. The 2014 Colquhoun et al. clarity paper pushed the field toward a consistent definition and terminology. JBI (formerly the Joanna Briggs Institute) has since published its own methodology, most recently updated by Peters and colleagues in 2021, and JBI’s version is what most Editverse scoping review protocols are built on. Our step-by-step JBI and PRISMA-ScR guide walks through all seven stages of that methodology in detail.

Scoping reviews use the PCC framework to define scope, rather than PICO:

• Population: who or what the review covers
• Concept: the core idea, intervention, or phenomenon being mapped
• Context: the setting, geography, or circumstances that bound the review

PCC is deliberately looser than PICO. A systematic review needs a Comparator and an Outcome because it is testing a specific effect. A scoping review often can’t specify those in advance, that’s frequently the whole reason for doing one: the field is too new, too broad, or too inconsistently reported to support a tightly framed effectiveness question yet.

What Is a Systematic Review?

A systematic review answers a specific, pre-specified question, usually about whether an intervention or exposure produces an outcome, using an exhaustive and reproducible search, explicit inclusion and exclusion criteria, formal quality/risk-of-bias appraisal of every included study, and (often, though not always) a meta-analysis that pools results into a single effect estimate.

Munn and colleagues, writing specifically to help authors choose between the two approaches, put the decision point plainly: when a question addresses the feasibility, appropriateness, meaningfulness, or effectiveness of a treatment or practice, a systematic review is “likely the most valid approach.” Systematic reviews are the right tool when you need to uncover the international evidence base on a specific effect, confirm or challenge current practice, resolve conflicting findings across existing studies, or produce a statement that will guide a clinical or policy decision.

The framework is PICO: Population, Intervention, Comparator, Outcome. Because the question is precise, the appraisal has to be too, every included study is formally assessed for risk of bias (commonly with RoB 2 for randomized trials or ROBINS-I for non-randomized studies), and the review is reported against the PRISMA 2020 checklist, not PRISMA-ScR. You can build your own compliant flow diagram, free, with our PRISMA 2020 flow diagram generator.

What Is a Narrative Review?

A narrative review is an expert-led synthesis of a topic without a fixed, pre-registered protocol. There’s no PCC or PICO requirement, no mandatory quality appraisal, and no standardized reporting checklist, which is exactly why narrative reviews are fast to produce and useful for orienting a reader to a field, but also why they carry a higher risk of selective citation and are rarely accepted as authoritative evidence on their own for a clinical or policy question. Editors, textbook chapters, and early background sections of a grant proposal are common, legitimate homes for a narrative review. A submission that needs to stand as primary evidence for a funding body or a clinical guideline usually needs one of the other two instead.

One more method worth distinguishing here, even though it isn’t in this comparison: if you’re not synthesizing primary studies at all but summarizing existing systematic reviews and meta-analyses, that’s an umbrella review, a review of reviews, and a different exercise again.

Scoping vs. Systematic vs. Narrative Review, at a Glance

The comparison below is the one reviewers actually check against when they read your methods section. Get any row wrong for your stated review type and expect a revision request.

How to Decide Which Review You Actually Need

If you are leaning toward a systematic review with meta-analysis, the deciding factor is often whether your evidence base can support pooling at all. Our guide to the minimum number of studies for a meta-analysis covers the point at which a structured narrative synthesis becomes the more defensible choice.

Munn and colleagues’ 2018 guidance for authors gives the clearest decision rule in the literature, and it’s worth quoting directly rather than paraphrasing into something vaguer. A systematic review is indicated when you need to:

• Uncover the international evidence on a specific practice or intervention
• Confirm current practice, address a known variation in practice, or identify new practices
• Identify and investigate conflicting results between existing studies
• Produce a statement to guide clinical or policy decision-making

A scoping review is indicated when the goal is instead to:

• Identify the types of evidence available in a given field
• Clarify key concepts or definitions in the literature
• Examine how research is conducted on a topic
• Identify key characteristics or factors related to a concept
• Serve as a precursor to a full systematic review
• Identify and analyze gaps in the existing knowledge base

Munn’s own framing of the fundamental difference is the fastest test to apply to your own question: a scoping review does “not aim to produce a critically appraised and synthesised result or answer to a particular question,” while a systematic review does, and must provide implications for practice. If you already know what you’re trying to prove, you probably need a systematic review. If you’re trying to find out what’s even out there before you can frame a provable question, you need a scoping review. If neither applies and you just need a grounded, readable overview for a course, a grant background section, or an editorial, a narrative review does the job without the protocol overhead.

A Real Scoping Review, Start to Finish

Worked examples in guides like this one are often invented for tidiness. Here’s a real one instead. Tao and colleagues (2023), published in Frontiers in Public Health, ran a PRISMA-ScR-compliant scoping review on integrating exercise prescription into medical care for non-communicable diseases. Its PCC framing:

• Population: patients diagnosed with non-communicable diseases
• Concept: exercise prescription (aerobic, resistance, balance, and other modalities) as treatment
• Context: inpatient and outpatient medical settings

The search ran across PubMed, Web of Science, MEDLINE, EMBASE, and ScienceDirect. The numbers, quoted directly from the paper: 10,951 records were retrieved. After duplicate removal, title/abstract screening, full-text reading, and manual searching, 28 studies were included, covering 1,368 patients in total. That funnel, from just under 11,000 records down to 28 included studies, is a realistic picture of what a scoping review search actually returns; it is not unusual for the vast majority of identified records to fall away at screening, which is exactly why PRISMA-ScR requires you to report the full flow rather than just the final count.

The review’s gap analysis, the actual point of doing a scoping review rather than a systematic one, found that research on exercise prescription for cardiovascular disease, respiratory disease, and diabetes specifically in inpatient and outpatient settings was limited; that included studies lacked diverse ethnic representation and consistent objective measurement; that cost-effectiveness and financial-barrier research was thin; and that qualitative research on patient and clinician attitudes toward exercise prescription was largely missing. None of that would have come out of a systematic review built around one narrow effectiveness question. Mapping the field first is what surfaced it, and that map is now a citable foundation for the systematic reviews and trials that should follow.

PRISMA-ScR Reporting: What It Adds

Once the review is done, how you report it is its own discipline. Tricco and colleagues (2018) published the PRISMA-ScR checklist specifically because the standard PRISMA 2020 checklist doesn’t fit how scoping reviews are actually conducted and reported. PRISMA-ScR has 22 checklist items, 20 essential and 2 optional, adapted from PRISMA 2020’s structure but changed where scoping methodology diverges from systematic review methodology. Our item-by-item breakdown of all 22 items covers each one individually. The differences that matter most in practice:

• PRISMA-ScR uses “sources of evidence” rather than “studies” throughout, since scoping reviews routinely include guidelines, reports, and other grey literature that “studies” doesn’t cover.
• It has a dedicated item for describing how the results were charted, the extraction and mapping step that has no direct systematic-review equivalent.
• It includes an optional item for reporting any stakeholder consultation exercise, JBI’s optional sixth stage, which systematic reviews don’t have a slot for at all.
• It does not require a risk-of-bias or quality appraisal section, because a scoping review isn’t rating study quality in the first place.

You can preview exactly what your own flow diagram will look like, with your own numbers, using the free PRISMA-ScR flow diagram generator; it runs entirely in your browser and exports at journal-ready resolution.

Mistakes That Get Protocols Sent Back

Patterns Editverse sees repeatedly when a scoping or systematic review protocol comes back for revision before work has even properly started:

• Calling it a scoping review, then writing it like a systematic review (or the reverse). If your abstract talks about “effectiveness” and reports a pooled effect size, a reviewer who specializes in scoping methodology will flag the mismatch immediately, whatever your methods section calls it.
• Skipping quality appraisal when the question actually needed one. If your research question is precise enough to test an effect, dropping risk-of-bias assessment to save time doesn’t turn it into a legitimate scoping review, it turns it into an underpowered systematic review.
• A PCC (or PICO) that’s too broad to search. “Population: adults. Concept: health. Context: everywhere” isn’t a scope, it’s an absence of one. A workable PCC should let a methodologist build a search string from it without further questions.
• Not registering the protocol. Both PROSPERO and OSF Registries accept scoping review protocols now, and an unregistered protocol invites the reviewer question of what changed between the plan and the write-up.
• Reporting “studies” when the review actually included grey literature. PRISMA-ScR’s own terminology, “sources of evidence,” exists for this reason. Using “studies” throughout when your inclusion criteria clearly cover guidelines and reports is an easy, avoidable inconsistency.
• Using the wrong flow diagram template. A scoping review reported against a PRISMA 2020 (not PRISMA-ScR) diagram is one of the fastest ways to signal, before a reviewer reads a single sentence of your methods, that the wrong framework was used somewhere upstream.

Scoping Review, Systematic Review, or Narrative Review, Which Should You Order?

If your topic is broad, new, or too inconsistently studied to support a precise effectiveness question yet, or if you need a defensible map of the field before writing a grant or a full systematic review protocol, that’s a scoping review. Editverse delivers one at a fixed $1,200, protocol through publication-ready manuscript, built on JBI methodology with the PCC framework and reported to PRISMA-ScR, in 6-10 weeks standard (4-6 weeks rush). Every deliverable arrives ready for journal submission; if you need broader manuscript writing support beyond the review itself, that’s covered too.

If you already have a specific, testable question about whether an intervention or exposure produces an outcome, and you need quality appraisal and (usually) a pooled estimate, you need our systematic review service instead. We’ll tell you before work starts if your question is actually shaped for one review type or the other, not after a rush job has already gone in the wrong direction.

If you’re not sure which of the two you need, that uncertainty is itself informative: it usually means a scoping review first is the right move, since one of a scoping review’s standard outputs is a gap analysis that tells you exactly what a follow-up systematic review would need to test.

Conclusion

The scoping review vs systematic review vs narrative review decision isn’t a formality to settle after the fact, it’s the decision that determines your framework (PCC or PICO), whether quality appraisal applies, which PRISMA extension you report against, and how long the project realistically takes. Get it right at the protocol stage and the rest of the review follows a known, defensible path. Get it wrong and the correction usually costs more time than getting it right the first time would have.

References

• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32. DOI: 10.1080/1364557032000119616.
• Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69. PMID: 20854677.
• Colquhoun HL, Levac D, O’Brien KK, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol. 2014;67(12):1291-1294. PMID: 25034198.
• Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143. PMID: 30453902.
• Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-473. PMID: 30178033.
• Peters MDJ, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2021. PMID: 33038124.
• Tao D, Awan-Scully R, Cole A, Gao Y, Ash GI, Gu Y, Dutheil F, Sun Y, Baker JS. Integration of exercise prescription into medical provision as a treatment for non-communicable diseases: A scoping review. Front Public Health. 2023;11:1126244. PMID: 37501942.
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. PMID: 33782057.